Insights Into Cervical Cancer 2024
Perspectives on drivers in treatment decisions in the management of cervical cancer
Central – April 20, 2024
Faculty Chair
Kathleen Moore, MD, MS
OU Health Stephenson Cancer Center, Oklahoma City, OK, USA
Northeast – August 24, 2024
Faculty Chair
Susana Campos, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, USA
Midwest – September 21, 2024
Faculty Chair
Thomas C Krivak, MD
UPMC, Pittsburgh, PA, USA
California – October 2024
Faculty Chair
Krishnansu Tewari, MD
Memorial Care Todd Cancer Institute, Long Beach, CA, USA
More Information
- Dallas, TX
- Arkansas, Kansas, Louisiana, Missouri, Oklahoma, Texas
More Information
- Philadelphia, PA
- Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Chicago, IL
- Illinois, Indiana, Iowa, Michigan, Minnesota, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin
More Information
- San Diego, CA
- California
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of cervical cancer
- Disease state and data presentations were developed in conjunction with a national or regional oncology expert
- Insights were obtained on the management of patients with cervical cancer and therapy strategies in second line and beyond
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors was composed of 10–15 medical oncologists representative of each region
